Prospective, Head-to-Head Study of Three Computerized Neurocognitive Assessment Tools Part 2: Utility for Assessment of Mild Traumatic Brain Injury in Emergency Department Patients
Overview
Psychology
Authors
Affiliations
Objectives: The aim of this study was to evaluate the reliability and validity of three computerized neurocognitive assessment tools (CNTs; i.e., ANAM, DANA, and ImPACT) for assessing mild traumatic brain injury (mTBI) in patients recruited through a level I trauma center emergency department (ED).
Methods: mTBI (n=94) and matched trauma control (n=80) subjects recruited from a level I trauma center emergency department completed symptom and neurocognitive assessments within 72 hr of injury and at 15 and 45 days post-injury. Concussion symptoms were also assessed via phone at 8 days post-injury.
Results: CNTs did not differentiate between groups at any time point (e.g., M 72-hr Cohen's d=-.16, .02, and .00 for ANAM, DANA, and ImPACT, respectively; negative values reflect greater impairment in the mTBI group). Roughly a quarter of stability coefficients were over .70 across measures and test-retest intervals in controls. In contrast, concussion symptom score differentiated mTBI vs. control groups acutely), with this effect size diminished over time (72-hr and day 8, 15, and 45 Cohen's d=-.78, -.60, -.49, and -.35, respectively).
Conclusions: The CNTs evaluated, developed and widely used to assess sport-related concussion, did not yield significant differences between patients with mTBI versus other injuries. Symptom scores better differentiated groups than CNTs, with effect sizes weaker than those reported in sport-related concussion studies. Nonspecific injury factors, and other characteristics common in ED settings, likely affect CNT performance across trauma patients as a whole and thereby diminish the validity of CNTs for assessing mTBI in this patient population. (JINS, 2017, 23, 293-303).
Brett B, Klein A, Vazirnia P, Omidfar S, Guskiewicz K, McCrea M J Neurotrauma. 2024; 41(19-20):2307-2322.
PMID: 38661548 PMC: 11564850. DOI: 10.1089/neu.2023.0609.
Ding H, Kim M, Searls E, Sunderaraman P, De Anda-Duran I, Low S Front Neurol. 2024; 15:1340710.
PMID: 38426173 PMC: 10902432. DOI: 10.3389/fneur.2024.1340710.
Anderson E, Talukdar T, Goodwin G, Di Pietro V, Yakoub K, Zwilling C Brain Commun. 2023; 5(4):fcad215.
PMID: 37649639 PMC: 10465085. DOI: 10.1093/braincomms/fcad215.
Toman E, Riley M, Hodgson S, Yakoub K, Cooper L, Bishop J BMJ Open. 2022; 12(9):e062030.
PMID: 36130754 PMC: 9494594. DOI: 10.1136/bmjopen-2022-062030.
The Clinical Utility of the Child SCAT5 for Acute Concussion Assessment.
Erdman N, Kelshaw P, Hacherl S, Caswell S Sports Med Open. 2022; 8(1):104.
PMID: 35962887 PMC: 9375738. DOI: 10.1186/s40798-022-00499-8.